Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)
Despite improvements in medical care, patients with advanced cancer still experience substantial symptom distress. There is increasing interest in the use of medicinal cannabinoids, but there is little high qu...
Source: BMC Palliative Care - Category: Palliative Care Authors: Phillip Good, Alison Haywood, Gauri Gogna, Jennifer Martin, Patsy Yates, Ristan Greer and Janet Hardy Tags: Study protocol Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Oral Cancer | Palliative | Palliative Care | Study